Pharmaceutical Group Sues to Block Medicare's New Drug Price Negotiation Powers

• The drug industry has launched multiple lawsuits against Medicare's ability to negotiate lower drug prices for seniors.
• PhRMA, the largest pharmaceutical lobbying group, argues the policy is unconstitutional and will harm innovation.
• The Biden administration says the law is legal and will vigorously defend it in court.
• If allowed to proceed, Medicare would start negotiating prices for certain expensive drugs in 2026.
• The policy is expected to save Medicare $102 billion over 10 years, reducing costs for seniors but cutting into drugmaker profits.

10 Articles

HuffPost The Hill CNBC Washington Post Associated Press CNN The Hill Stat News The Seattle Times The Hill